Paediatric Haematology and Leukaemia
The sponsor is involved in clinical research on acute promyelocytic leukaemia in children and adolescents, with attention to treatment strategies for both standard-risk and high-risk disease.
- Acute promyelocytic leukaemia
- Pediatric oncology
- Risk-adapted therapy
Its activity in this area includes collaborative work across multiple international sites focused on improving outcomes in young patients with haematologic malignancies.
Bone Oncology and Sarcoma
The organisation also supports research in metastatic osteosarcoma, addressing treatment approaches for patients with advanced bone cancer.
- Metastatic osteosarcoma
- Bone sarcoma
- Metastatic disease
This research area reflects an interest in therapies aimed at improving disease control in aggressive orthopaedic oncology settings.
Combination Therapy in Oncology
Clinical work funded by the sponsor includes studies of combination treatment approaches in both haematological and solid tumours, with emphasis on integrating targeted agents alongside established chemotherapy or standard treatment.
- Combination therapy
- Targeted oncology treatment
- Standard-of-care regimens
The sponsor’s portfolio includes research into therapeutic pairings designed to address difficult-to-treat paediatric cancers.
Multicentre Paediatric Cancer Research
The sponsored trials are conducted through a broad network of collaborating sites across several countries, supporting research in international paediatric oncology and cross-border clinical collaboration.
- Multicentre studies
- International collaboration
- Paediatric cancer networks
This scope indicates active involvement in coordinated research efforts for rare and complex childhood cancers.
